RNA-binding proteins as regulators of gene expression

Current Opinion in Genetics and Development

Volumn 7, Issue 3, 1997, Pages 345-353

  Siomi, Haruhiko ^a   Dreyfuss, Gideon ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; COMPLEMENTARY RNA; RNA BINDING PROTEIN;

EUKARYOTE; GENE EXPRESSION REGULATION; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN RNA BINDING; REVIEW; RNA PROCESSING; RNA SEQUENCE; SIGNAL TRANSDUCTION;

EUKARYOTA;

EID: 0030858706     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(97)80148-7     Document Type: Article

References (70)

1. St Johnston D: The intracellular localization of messenger RNAs. Cell 1995, 81:161-170.
2. Curtis D, Lehmann R, Zamore PD: Translational regulation in development. Cell 1995, 81:171-178.
3. Wickens M, Kimble J, Strickland S: Translational control of developmental decisions. In Translational Control. Edited by Hershey JWB, Mathews MB, Sonenberg N. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1996:411-450.
4. Chabot B: Directing alternative splicing: cast and scenarios. Trends Biochem Sci 1996, 12:472-477.
5. Proudfoot N: Ending the message is not so simple. Cell 1996, 87:779-781.
6. Smith HC, Sowden MP: Base-modification mRNA editing through deamination - the good, the bad and the unregulated. Trends Biochem Sci 1996, 12:418-424.
7. Kozak M: An analysis of vertebrate mRNA sequences: intimations of translational control. J Cell Biol 1991, 115:887-903.
8. Foulkes NS, Sassone-Corsi P: More is better: activators and repressors from the same gene. Cell 1992, 68:411-414.
9. Burd CG, Dreyfuss G: Conserved structures and diversity of functions of RNA-binding proteins. Science 1994, 265:615-621.
10. Kiledjian M, Burd CG, Portman DS, Gorlach M, Dreyfuss G: Structure and function of hnRNP proteins. In RNA-Protein Interactions: Frontiers in Molecular Biology. Edited by Nagai K, Mattaj IW. Oxford: IRL Press; 1994:127-149.
11. Nagai K: RNA-protein complexes. Curr Opin Struct Biol 1996, 5:53-61.
12. Oubridge C, Ito N, Evans PR, Teo CH, Nagai K: Crystal structure at 1.92A resolution of the RNA-binding domain of the U1A spliceosomal protein complexed with an RNA hairpin. Nature 1994, 372:432-438.
13. Liljas A, Garber M: Ribosomal proteins and elongation factors. Curr Opin Struct Biol 1995, 5:721-727.
14. Bycroft M, Hubbard TJP, Proctor M, Freund SMV, Murzin AG: The solution structure of the S1 RNA binding domain: a member of an ancient nucleic acid-binding fold. Cell 1997, 88:235-242.
15. Bycroft M, Grünert S, Murzin AG, Proctor M, St Johnston D: NMR solution structure of a dsRNA binding domain from Drosophila staufen protein reveals homology to the N-terminal domain of ribosomal protein S5. EMBO J 1995, 14:3563-3571. See annotation [16•].
16. Kharrat A, Macias MJ, Gibson TJ, Nilges M, Pastore A: Structure of the dsRNA binding domain of E. coli RNase III. EMBO J 1995, 14:3572-3584. This paper and [15•] show, using NMR methods, that the dsRBD has an α-β-β-β-α topology in which a three-stranded anti-parallel β sheet packs on one side against the two helices. Sequence conservation and mutagenesis suggest that the amino terminus of the second helix and a nearby loop interact with dsRNA.
17. Siomi H, Matunis MJ, Michael WM, Dreyfuss G: The pre-mRNA binding K protein contains a novel evolutionary conserved motif. Nucleic Acids Res 1993, 21:1193-1198.
18. Musco G, Stier G, Joseph C, Morelli MAC, Nilges M, Gibson TJ, Pastore A: Three-dimentional structure and stability of the KH domain: molecular insights into the fragile X syndrome. Cell 1996, 85:237-245. The KH domain consists of a stable β-α-α-β-β-α fold. Substitution of a well-conserved hydrophobic residue located on the second helix destroys the KH fold; a mutation of this position in FMR1 leads to a severe fragile X phenotype.
19. Berglund H, Rak A, Serganov A, Garber M, Hard T: Solution structure of the ribosomal RNA binding protein S15 from Thermus thermophilus. Nat Struct Biol 1997, 4:20-23.
20. King Y, Guha-Thakurta D, Draper DE: The RNA binding domain of ribosomal protein L11 is structurally similar to homeodomains. Nat Struct Biol 1997, 4:24-27. See annotation [21•].
21. Markus MA, Hinck AP, Huang S, Draper DE, Torchia DA: High resolution solution structure of ribosomal protein L11-C76, a helical protein with a flexible loop that becomes structured upon binding to RNA. Nat Struct Biol 1997, 4:70-77. The RNA-binding domain of L11-C76 contains three a helices that super-impose with homeodomain a helices. The carboxy-terminal end of the third helix appears to be involved in RNA binding.
22. Dubnau J, Struhl G: RNA recognition and translational regulation by a homeodomain protein. Nature 1996, 379:694-699. A Drosophila homeodomain protein bicoid directly binds the 3′-UTR of the caudal mRNA and acts as a translational repressor to generate an opposing gradient of the caudal protein. This is the first demonstration of a homeodomain protein binding to RNA with specificity.
23. Portman DS, Dreyfuss G: RNA annealing activities in HeLa nuclei. EMBO J 1994, 13:213-221.
24. Michael WM, Siomi H, Choi M, Pinol-Roma S, Nakielny S, Liu Q, Dreyfuss G: Signal sequences that target nuclear import and nuclear export of pre-mRNA-binding proteins. Cold Spring Harb Symp Quant Biol 1995, 60:663-668.
25. Rio DC: Splicing of pre-mRNA: mechanism, regulation and role in development. Curr Opin Genet Dev 1993, 3:574-584.
26. Cox JS, Walter P: A novel mechanism for regulating activity of a transcription factor controls the unfolded protein response. Cell 1996, 87:391-404. See annotation [27••].
27. i mRNA encoding the functional transcription factor. Interestingly, tRNA ligase as well as other proteins involved in pre-tRNA splicing have been localized near nuclear pores, suggesting that splicing of the HAC1 pre-mRNA occurs as it is exported to the cytoplasm to be translated.
28. Taylor SJ, Shalloway D: An RNA-binding protein associated with Src through its SH2 and SH3 domains in mitosis. Nature 1994, 368:867-871.
29. Fumagalli S, Totty NF, Hsuan JJ, Courtneidge SA: A target for Src in mitosis. Nature 1994, 368:871-874.
30. Wang LL, Richard S, Shaw AS: p62 association with RNA is regulated by tyrosine phosphorylation. J Biol Chem 1995, 270:2010-2013. Sam68 [70] can associate directly with src-family tyrosine kinases resulting in tyrosine phosphorylation of the protein. The ability of Sam68 to bind RNA is severely impaired when it is tyrosine phosphorylated, suggesting that Sam68 may play a critical role in cell cycle regulation to activate RNA.
31. Neel H, Gondran P, Weil D, Dautry F: Regulation of pre-mRNA processing by Src. Curr Biol 1995, 5:413-422.
32. Lee K, Haugen HS, Clegg CH, Braun RE: Premature translation of protamine 1 mRNA causes precocious nuclear condensation and spermatid differentiation. Proc Natl Acad Sci USA 1995, 92:12451-12455. Transgenic studies have shown that the 3′-UTR of Prm1 mRNA is both necessary and sufficient to mediate translational repression during spermatid differentiation. This paper shows that correct temporal synthesis of Prm1 is necessary for the transition from nucleohistones to nucleoprotamines.
33. Liu Q, Siomi H, Siomi MC, Fischer U, Zhang Y, Wan L, Dreyfuss G: Molecular characterization of the protein products of the fragile X syndrome gene and the survival of motor neurons gene. Cold Spring Harb Symp Quant Biol 1996, 61:689-699.
34. Reijo R, Lee TY, Salo P, Alagappan R, Brown LG, Rosenberg M, Rozen S, Jaffe T, Straus D, Hovatta O et al.: Diverse spermatogenic defects in human caused by Y chromosome deletions encompassing a novel RNA-binding protein gene. Nat Genet 1995, 10:383-393.
35. Eberhart CG, Maines JZ, Wasserman SA: Meiotic cell cycle requirement for a fly homologue of human deleted in azoospermia. Nature 1996, 381:783-785. A Drosophila male-fertility gene, boule, is related to the human gene DAZ (for deleted in azoospermia), a candidate male fertility gene located on the Y chromosome (see [34]). Interestingly, boule is located on an autosome. Loss of boule function results in block of meiotic divisions.
36. Delbridge ML, Harry JL, Toder R, Waugh O'Neill RJ, Ma K, Chandley AC, Marshall Graves JA: A human candidate spermatogenesis gene, RBM1, is conserved and amplified on the marsupial Y chromosome. Nat Genet 1997, 15:131-136.
37. Verkerk AJMH, Pieretti M, Sutcliffe J, Fu YH, Kuhl DP, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang FP et al.: Identification of a gene (FMR1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 1991, 65:905-914.
38. Oostra BA, Willems PJ: A fragile gene. Bioessays 1995, 17:941-947.
39. De Boulle K, Verkerk AJMH, Reyniers E, Vits L, Hendrichs J, Van Roy B, Van den Bos F, De Graaff E, Oostra BA, Willems PJA: Point mutation in the FMR1 gene associated with fragile X mental retardation. Nat Genet 3:31-35.
40. Siomi H, Choi M, Siomi MC, Nussbaum RL, Dreyfuss G: Essential role for KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome. Cell 1994, 77:33-39.
41. Mahone M, Saffman EE, Lasko PF: Localized Bicaudal-C encodes a protein containing a KH domain, the RNA binding motif of FMR1. EMBO J 1995, 14:2043-2055.
42. Jones AR, Schedl T: Mutations in gld-1, a female germ cell-specific tumor suppressor gene in Caenorhabditis elegans, affect a conserved domain also found in Src-associated protein Sam68. Genes Dev 1995, 9:1491-1504.
43. Timchenko LT, Caskey CT: Trinucleotide repeat disorders in humans: discussions of mechanisms and medical issues. FASEB J 1996, 10:1589-1597.
44. McLaughlin BA, Spencer C, Eberwine J: CAG trinucleotide RNA repeats interact with RNA-binding proteins. Am J Hum Genet 1996, 59:561-569. Several neurological diseases are associated with an expanded CAG repeat. The authors identified cytoplasmic RNA-binding proteins that interact with CAG repeats in a tissue-specific and CAG length-dependent manner. This paper also presents a model whereby the expanded CAG repeats may act as a sink to bind and titrate away RNA-binding proteins that are normally associated with other cellular CAG-containing mRNAs.
45. Timchenko LT, Miller JW, Timchenko NA, DeVore DR, Datar KV, Lin L, Roberts R, Caskey CT, Swanson MS: Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res 1996, 24:4407-4414.
46. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP: Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996, 87:493-506. The 1.9 kb human genomic fragment containing promoter sequences and exon 1 carrying expansions of approximately (CAG)130 of Huntington's disease gene has been shown to be sufficient to generate a progressive neurological phenotype that displays many of the characteristics of Huntington's disease. This work suggests that expression of expanded CAG repeats encoding polyglutamine may be sufficient to generate a mouse model of Huntington's disease which will assist in an eventual understanding of the molecular pathology of the disease.
47. Gilbert SF: Developmental Biology, edn 4. Sunderland, MA: Sinauer Associates, Inc.; 1994:8-10.
48. Tessier-Lavigne M, Goodman CS: The molecular biology of axon guidance. Science 1996, 274:1123-1133.
49. Van Minnen J: RNA in the axonal domain: a new dimension in neuronal functioning? Histochem J 1994, 26:377-391.
50. Crino PB, Eberwine J: Molecular characterization of the dendritic growth cone: regulated mRNA transport and local protein synthesis. Neuron 1996, 17:1173-1187. This paper describes the isolation and characterization of mRNAs from single dendritic growth cones. It also shows, using single dendritic transfection, that local protein synthesis occurs in dendrites and growth cones.
51. Kang H, Schuman EM: A requirement for local protein synthesis in neurotrophin-finduced hippocampal synaptic plasticity. Science 1996, 273:1402-1406. The data suggest that neurotrophins stimulate the local synthesis of proteins in either axonal or dendritic compartments that are required for the induction of synaptic enhancement. The newly synthesized proteins may act locally to enhance postsynaptic responsiveness or may communicate with the presynaptic terminal to increase neurotransmitter release.
52. Sen-Gupta DB, Zhang B, Kraemer B, Prochart P, Fields S, Wickens M: A three-hybrid system to detect RNA-protein interactions in vivo. Proc Natl Acad Sci USA 1996, 93:8496-8501. A three-hybrid system is a variation of the yeast two-hybrid technology; it allows selection for specific RNA-binding proteins using the following features. A vector expressing the lexA DNA-binding domain fused to the phage MS-2 protein is integrated into the yeast genome. A vector expressing a hybrid RNA that contains the MS-2 protein-binding site and the target RNA sequence of interest and a cDNA library fused to the Gal4 activation domain are introduced into the yeast. Expression of a fusion protein that interacts with the target RNA sequence will result in activation of transcription from promoters that bind the lexA-MS2 fusion protein.
53. Harada K, Martin SS, Frankel AD: Selection of RNA-binding peptides in vivo. Nature 1996, 380:175-179. In the two-plasmid system used in this paper, the antiterminator protein N is expressed under the control of a tac promoter and β-galactosidase is also expressed under control of a tac promoter from the second plasmid with the N-utilization (nut) and termination sites upstream of lacZ. Because the interaction of N with nut is mediated by an arginine-rich region of N, it is anticipated that the interaction may be replaced by other arginine-rich peptide-RNA interactions.
54. Jain C, Belasco JG: A structural model for the HIV-1 Rev-RRE complex deduced from altered-specificity Rev variants isolated by a rapid genetic strategy. Cell 1996, 87:115-125. The method used in this paper is to subject lacZ expression to translational control by a heterologous RNA-binding protein by inserting a binding site for that protein just upstream of an RNA element important for translation initiation (i.e. the Shine-Dalgarno element). Binding by the RNA-binding protein in E. coli would sterically hinder ribosome binding and reduce β-galactosidase production.
55. McCracken S, Fong N, Yankulov K, Ballantyne S, Pan G, Greenblatt J, Patterson SD, Wickens M, Bentley DL: The C-terminal domain of RNA polymerase II couples mRNA processing to transcription. Nature 1997, 385:357-361. This paper shows that the carboxy-terminal domain of the RNA polymerase II large subunit is required for efficient RNA processing such as splicing and polyadenylation. The carboxy-terminal domain appears to associate directly with splicing factors and 3′ processing factors. The data suggest that splicing and polyadenylation are not only coupled to one another but also to transcription.
56. Takagaki Y, Seipelt RL, Peterson ML, Manley JL: The polyadenylation factor CstF-64 regulates alternative processing of IgM heavy chain pre-mRNA during B cell differentiation. Cell 1996, 87:941-952. Experiments described in this paper show that overexpression of one of the polyadenylation factors (CstF-64) in a B cell line increases the concentration of intact CstF and is sufficient to switch IgM heavy chain expression from the membrane-bound form to the secreted form.
57. Dietz HC, Kendzior RJ Jr: Maintenance of an open reading frame as an additional level of scrutiny during splice site selection. Nat Genet 1994, 8:183-188.
58. Gorlach M, Wittekind M, Beckman RA, Mueller L, Dreyfuss G: Interaction of the RNA-binding domain of the hnRNP C proteins with RNA. EMBO J 1992, 11:3289-3295.
59. Bevilacqua PC, Cech TR: Minor-groove recognition of double-stranded RNA by the double-stranded RNA-binding domain from the RNA-activated protein kinase PKR. Biochemistry 1996, 35:9983-9994.
60. Draper BW, Mello CC, Bowerman B, Hardin J, Priess JR: Mex-3 is a KH domain protein that regulates blastomere identity in early C. elegans embryos. Cell 1996, 87:205-216.
61. Urlaub H, Kruft V, Bischof O, Muller E-C, Wittmann-Liebold B: Protein-rRNA binding features and their structural and functional implications in ribosomes as determined by cross-linking studies. EMBO J 1995, 14:4578-4588.
62. Schwabe JWR, Klug A: Zinc mining for protein domains. Nat Struct Biol 1994, 1:345-349.
63. Ghisolfi L, Joseph G, Amalric F, Erard M: The glycine-rich domain of nucleolin has an unusual supersecondary structure responsible for its RNA-helix-destabilizing properties. J Biol Chem 1992, 267:2955-2959.
64. Puglisi JD, Chen L, Blanchard S, Frankel AD: Solution structure of a bovine immunodeficiency virus Tat-TAR peptide-RNA complex. Science 1995, 270:1200-1203.
65. Battiste JL, Mao H, Rao NS, Tan R, Muhandiram DR, Kay LE, Frankel AD, Williamson JR: Alpha helix-RNA major groove recognition in an HIV-1 Rev peptide-RRE RNA complex. Science 1996, 273:1547-1551.
66. Lindahl M, Svensson LA, Liljas A, Sedelnikova SE, Eliseikina IA, Fomenkova NP, Nevskaya N, Nikonov SV, Garber MB, Muranova TA et al.: Crystal structure of the ribosomal protein S6 from Thermus thermophilus. EMBO J 1994, 13:1249-1254.
67. Predki PF, Nayak M, Gottlieb MBC, Regan L: Dissecting RNA-protein interactions: RNA-RNA recognition by Rop. Cell 1995, 80:41-50.
68. Navaratnam N, Bhattacharya S, Fujino T, Patel D, Jarmuz AL, Scott J: Evolutionary origins of apoB mRNA editing: catalysis by a cytidine deaminase that has acquired a novel RNA-binding motif at its active site. Cell 1995, 81:187-195.
69. Hentze MW: Enzymes as RNA-binding proteins: a role for (di)nucleotide-binding domains? Trends Biochem Sci 1994, 19:101-103.
70. Lock P, Fumagali S, Polakis P, McCormick F, Courtneidge SA: The human p62 cDNA encodes Sam68 and not the RasGAP-associated p62 protein. Cell 1996, 84:23-24.